Abstract A functional lmpanment m vasochlator tone may be important m the pathogenesls and/or maintenance of elevated peripheral vascular resistance m hypertension Previous studies of hypertenstve subJects have demonstrated impaired P-adrenerglcmediated vasochlatlon paralleling a reduction m lymphocyte P-adrenergic-stimulated adenylyl cyclase activity We have suggested that this impairment IS related to a defect m G-protein function. To determine whether this defect alters the coupling between the G-protein complex and adenylyl cyclase, we performed [3H]forskolm bmchng studies m lymphocytes from hypertensive subjects, older normotensive subjects, and younger normotensive control subjects Maximal specific [3H]forskohn bmclmg was used as an index of adenylyl cyclase bmdmg sites Gpp(NH)p-, NaF/AlC& and Isoproterenol-stimulated bmdmg were used as m&es of G-protem/adenylyl cyclase coupling In and/or mamtenance of the hypertensive state 1~ Previous studies from our 1aboratorylJ and those of other+ have shown impaired P-adrenergic-mechated vasodilatlon in younger predommantly white hypertenslve subJects Impared P-adrenerglc-mediated vasodilation has also been reported with agings-8 but not by all investigators.9
and/or mamtenance of the hypertensive state 1~ Previous studies from our 1aboratorylJ and those of other+ have shown impaired P-adrenergic-mechated vasodilatlon in younger predommantly white hypertenslve subJects Impared P-adrenerglc-mediated vasodilation has also been reported with agings-8 but not by all investigators.9
To explain the defect m /3-adrenerglc-mechated function with hypertension, our laboratory (and those of others) has focused on the /I-adrenoceptortadenylyl cyclase complex 10~1 Activation of this system 1s dependent predommantly on the interaction of three pro&n components (1) the receptor that contains the recognition site for hormone binding, (2) the enzyme adenylyl cyclase that catalyzes synthesis of CAMP, and (3) the guamne nucleotlde regulatory protein complex (G-protein), a heterotrimer that couples receptor occupancy with stimulation of catalytic activity In the study of alterations m adrenerglc responses m hypertension, the lymphocyte has been used as a model for the human vascular P-adrenoceptor/G-protein/adenylyl cyclase complex. The validity of this approach is based on several lines of evidence. First, previous studies have reported that lymphocyte lsoproterenol-stimulated adenylyl cyclase activity is correlated with lsoproterenol-stimulated venodllation. * Second, indices of ,&adrenoceptortG-protein couplmg m lymphocytes (viz, P-adrenoceptor-mediated adenylyl cyclase activity and the ability to form the high affinity state In hypertension, the lmpalrment m P-adrenerglc-mediated response m lymphocytes has been related to a defect at the level of the receptor/G-protein Interaction 13~1 Our most recent studies have suggested an impairment m stimulatory G-protein (GJ function (but not expresslon) 22 These stuches also suggested a divergent pattern of alterations m G-protein function between hypertensive and older subjects Therefore, the current evidence to date would suggest that the impairment m lymphocyte P-adrenerglc subjects was related to an impairment m G-protein function (at least in part) and differs from the alterations m P-adrenergic responses seen with aging. However, m human hypertensive SubJects, the studies addressing this issue have depended almost entirely on assessment of catalytic activity determined from alterations of CAMP concentrations These studies generally use membrane preparations and are dependent on a number of other modulators, mcludmg phosphochesterases, ATP, and ions (eg, Ca2+) that selectively affect catalytic function. 23.24 Our recent studies suggesting Impaired G-protem-mediated effects were based on reduced cholera toxin-mediated ADP-nbosylation of the (Y subunit of G, However, the relationship between alterations in the extent of cholera toxmmediated ADP ribosylation and G-protein function 1s indirect (as discussed m Reference 22) An alternative approach has been developed to assess G-protem/adenylyl cyclase interactions in intact and permeablhzed cells m-Feldman and Chorazyczewskz G-Proteins in Hypertension dependent of the determmatlon of CAMP levels *S-VJ It utlllzes the affinity of the diterpme forskohn to bind selectively to adenylyl cyclase. Notably, the effects of forskolin on adenylyl cyclase are modulated by G-protein mteractlons The extent of forskohn-stimulated actlvatlon of adenylyl cyclase 1s enhanced by an mteractlon with Gs.31 Furthermore, forskohn bmdmg to adenylyl cyclase is enhanced by stabihzatlon of the mteractlon between the GffS and adenylyl cyclase.27.29 With this techmque, G-protem fun&on has been assessed by the extent to which G-protem-and/or receptor-specific hgands enhance specific [3H] forskohn bmdmg This approach has been used successfully to assess the regulation of G-protem function.2527 Therefore, to assess alterations m G-protein function m hypertension independent of the functional assessment of CAMP concentrations, we have determined the extent of G-protein-mediated enhancement of ['H]forskolm bmdmg The data to be presented demonstrate that G-protein-enhanced [ 'Hlforskolm bmdmg 1s reduced in lymphocytes from hypertensive but not older normotensive subjects Further, G-protein-enhanced labeling 1s slgmficantly inversely correlated with blood pressure independent of age, consistent with a blood pressure-related reduction m human lymphocyte G-protein function.
Subject Protocol

Methods
Younger and older normotensive subjects and younger borderlme hypertensive subjects were studled Younger normotenslve subjects were between the ages of 20 to 36 years, healthy, and not takmg any mechcatlons on a regular basis or any medIcations for at least 1 month before study Older normotenslve SubJects were between the ages of 45 and 63 years, healthy, and not takmg any medlcatlons on a regular basis or any me&a-tions for at least 1 month before study Hypertensive SubJects were all white, between the ages of 22 and 36 years, otherwise healthy, and had neither renal nor cardiovascular comphcatlons Hypertensive subJects had not taken any antihypertensive medIcations (or any other mechcatlons) for at least 1 month before study The criteria for classifying blood pressure statue of subjects were as described previously 22 The borderline or mildly hypertensive subjects had pressures > 140/90 mm Hg on at least 20% of daytime automatic ambulatory blood pressure readings (Spacelab model 90207) All subjects were mstlucted to mamtain a high sodium intake for 3 days before study Compltance with dietary mstruction was assessed by urmary sodmm determmatlons based on overnight collections The protocol was approved by the Human Subjects Review Committee, University of Western Ontarlo Informed consent was obtained from each subJect before study
Assessment of [3H]Forskolin Binding in Human Lymphocytes
[3H]Forskohn bmdmg was assessed m mononuclear leukocyte preparations Mononuclear leukocytes were separated from whole blood by the method of BoyumQ and as described previously 22 Mononuclear cells were harvested via separation on FItoll-Hypaque gradients and resuspended m Hanks' balanced salt solution (HBSS, pH 7 4 at 4°C) with 33 mmol/L HEPES, 0 5 mmol/L EDTA, and 1 mmol/L magnesium sulfate (buffer A), followed by centrifugation for 10 minutes at 400g and resuspension m buffer A with dlgitomn (10 pg/mL) for 15 mmutes at 4°C Cells were washed twice at 400s for 10 minutes at 4°C m buffer A without dlgitonm and resuspended m HBSS (pH 7 4 at 4°C) with 33 mmol/L HEPES, 1 25 mmol/L EDTA, and 5 mmol/L magnesium sulfate The cells were Incubated at a concentration of 8~ 1Oh cells/mL for 3 horns at 4°C Inmal studies showed ['Hlforskolm bmdmg achieved steady state before 3 hours at 4°C at the concentrations of radlohgand used Incubations were termmated by vacuum filtration with rapld washing (less than 5 seconds) with a l/10 ddutlon ot buffer A at 4°C Radloactlvlty on filters was measured by hquld scmtdlation spectroscopy (Beckman LS 6000) Nonspecific bmdmg was determined as the extent of [lH] To determine whether G-protein-stimulated [ "Hlforskolin binding was acutely regulatable by exposure to P-adrenergic agonists, whole blood samples from younger normotensive subjects were pretreated with isoproterenol (10 pmol/L for 15 minutes), followed by lymphocyte separation, permeabilization, and assessment of ['Hlforskolin binding at a concentration of 50 nmol/L. Using this protocol previously, we have shown a significant reduction in P-adrenergic-stimulated adenylyl cyclase activity with a homologous pattern (ie, no alterations in G-protein-stimulated adenylyl cyclase activity '2). Following pretreatment with the P-adrenergic agonist, neither isoproterenol-, Gpp(NH)p-, nor NaF/AlCl,-stimulated specific ['Hlforskolin binding was reduced (92t9%, 108?31%, and 103115% of control binding, respectively). No significant alterations in overnight sodium excretion were detected between older and hypertensive subjects versus younger normotensive control subjects. No significant difference in blood pressure was apparent between older and younger control subjects. Normotcnsive and hypertensive subjects were comparably aged. Body mass did not differ among the three groups (Table) .
Basal (Fig 2) . In contrast, no alterations in isoproterenol-or Gpp(NH)p-stimulated ['Hlforskolin binding were apparent in lymphocytes from older subjects (Fig  2) . Further, no alterations in NaF/AlCl,-mediated enhancement Of ['Hlforskolin binding were evident between hypertensive subjects and either older or younger normotensive groups (Fig 2) . Overall, isoproterenoland Gpp(NH)p-mediated enhancement of ['Hlforskolin binding were highly correlated (~=.76, P<.OOl , Fig 3) Fig 4) . In contrast, there was no correlation between age and either lsoproterenol-or Gpp(NH)p-stimulated [3H]forskolm bmdmg (data not shown).
Discussion
Alterations m receptor-stimulated and G-protem-stlmulated adenylyl cyclase activity have previously been demonstrated m lymphocytes from hypertensive SubJects (as discussed above) Furthermore, alterations m G-protein function have been suggested based on reduced cholera toxin-mediated substrate labeling of the a-subunit of the stlmulatory G-protem.22 The present studies demonstrate that these alterations m lymphocyte G-protein properties parallel a reduction m G-protein-stimulated [ 'Hlforskolm binding In contrast, no alterations m G-protein-stimulated [3H]forskohn binding were apparent m lymphocytes from older normotenslve subjects Forskolm has been previously shown to interact with adenylyl cyclase with a high affinity, and the use of this reagent was instrumental m the original punficatlon of the enzyme 36 It 1s notable that forskolm has CAMP-mdependent effects, including mhibltlon of glucose transport, of nicotmlc receptor function, and of voltage-dependent potassium channels 36 However, these non-adenylyl cyclasemediated effects of forskolm are common to 1,9 dldeoxyforskolm, a naturally occurring analogue of forskolm that neither inhibits high-affinity bmdmg of [ 'Hlforskolm nor activates adenylyl cyclase 36 The high affinity of [3H]forskolm bmdmg demonstrated m these studies, and lack of effect of 1,9 dideoxyforskolm m mhlbltmg [3H]forskolm binding, 1s consistent with an effect of forskolm bmdmg to adenylyl cyclase In the lymphocyte, consistent with other models,*s-29 both receptor and G-protein specific stimulators slgmficantly enhance [3H]forskolin bmdmg m respect to maximal bmdmg as well as to bmclmg affinity. The estimate of basal binding site concentration of 3012 sites/cell is quantitatively similar to P-adrenoceptor density (of approximately 10' sites/cell-12).
The Vol29, No 1, Part 2 January 1997 a shaft in the Kd, but not the B,,, for bmdmg Addtttonally, NaF 1s a tyrosme phosphatase mhtbttor Recent studies have suggested that tyrosme kmases may have addittonal G-protem-independent effects on adenylyl cyclase 37 As dtscussed above, impaired G-protein-stimulated adenylyl cyclase activtty m lymphocytes from hypertensive SubJects has been previously reported Additionally, we have recently demonstrated a decrease m cholera toxin-mediated ADP rtbosylatton of Go, m lymphocytes from a comparable group of younger hypertensive subjects studied under identical condtttons 22 In those studtes, there were no alterations m Go, expresston as assessed by immunodetectton. Together with the present studies, a conststent impairment m G-protein function m lymphocytes from younger white hypertensive subjects has now been demonstrated usmg three dtstmct approaches Finally, these studies provide further evidence that alterations m lymphocyte P-adrenergtc tesponses m hypertenston are distinct from the pattern seen with aging As discussed above, an tmpatrment m lymphocyte ,&ad-renergtc responstveness has variably been seen with agmg However, these studies have been generally confounded by the age-dependent increase m blood pressure 3* In contrast, m the present study, blood pressures m older and younger normotenstve groups were virtually identical Our finding that overall G-protenmediated enhancement of [3H]forskolm bmdmg was mversely correlated with mean arterial pressure over all age groups studied 1s consistent with the hypothesis that agerelated alterations m this transmembrane signaling process may be confounded with the age-related increase m blood pressure In summary, these studies have demonstrated the utility of [3H]forskolm bmdmg in lymphocytes as a measure of G-protein function Furthermore, they demonstrate an tmpau-ment m G-protein-mediated function specific to lymphocytes from hypertensive subjects Overall, the present data, and those from previous studies, have suggested that m these younger white hypertensive SubJects, an impairment m G-protein function may underlie the tmpatrment m transmembrane $tgnalmg charactertstic of the defect m the P-adrenergtc receptor/G-protem/adenylyl cyclase complex m the hypertensive state
